Global Gene Therapy Market Size, Status and Forecast 2020-2026
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Gene therapy is a method that involves introducing genetic material into a person’s cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.
These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.
Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.
In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Therapy market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapy industry.
Based on our recent survey, we have several different scenarios about the Gene Therapy YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Therapy will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy market in terms of revenue.
Players, stakeholders, and other participants in the global Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Therapy market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy market.
The following players are covered in this report:
Gene therapy is a method that involves introducing genetic material into a person’s cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.
These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.
Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.
In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Therapy market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapy industry.
Based on our recent survey, we have several different scenarios about the Gene Therapy YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Therapy will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy market in terms of revenue.
Players, stakeholders, and other participants in the global Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Therapy market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy market.
The following players are covered in this report:
- Bluebird Bio
- Sangamo
- Spark Therapeutics
- Dimension Therapeutics
- Avalanche Bio
- Celladon
- Vical Inc.
- Advantagene
- Ex vivo
- In Vivo
- Cancer
- Monogenic
- Infectious disease
- Cardiovascular disease
- Other
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Monogenic
1.5.4 Infectious disease
1.5.5 Cardiovascular disease
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapy Industry
1.6.1.1 Gene Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Gene Therapy Market Perspective (2015-2026)
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapy Players by Market Size
3.1.1 Global Top Gene Therapy Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy Market Concentration Ratio
3.2.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2019
3.3 Gene Therapy Key Players Head office and Area Served
3.4 Key Players Gene Therapy Product Solution and Service
3.5 Date of Enter into Gene Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gene Therapy Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy Forecasted Market Size by Type (2021-2026)
5 GENE THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gene Therapy Market Size by Application (2015-2020)
5.2 Global Gene Therapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gene Therapy Market Size (2015-2020)
6.2 Gene Therapy Key Players in North America (2019-2020)
6.3 North America Gene Therapy Market Size by Type (2015-2020)
6.4 North America Gene Therapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Gene Therapy Market Size (2015-2020)
7.2 Gene Therapy Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy Market Size by Type (2015-2020)
7.4 Europe Gene Therapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Gene Therapy Market Size (2015-2020)
8.2 Gene Therapy Key Players in China (2019-2020)
8.3 China Gene Therapy Market Size by Type (2015-2020)
8.4 China Gene Therapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Gene Therapy Market Size (2015-2020)
9.2 Gene Therapy Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy Market Size by Type (2015-2020)
9.4 Japan Gene Therapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Gene Therapy Market Size (2015-2020)
10.2 Gene Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy Market Size by Application (2015-2020)
11 INDIA
11.1 India Gene Therapy Market Size (2015-2020)
11.2 Gene Therapy Key Players in India (2019-2020)
11.3 India Gene Therapy Market Size by Type (2015-2020)
11.4 India Gene Therapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Gene Therapy Market Size (2015-2020)
12.2 Gene Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Bluebird Bio
13.1.1 Bluebird Bio Company Details
13.1.2 Bluebird Bio Business Overview and Its Total Revenue
13.1.3 Bluebird Bio Gene Therapy Introduction
13.1.4 Bluebird Bio Revenue in Gene Therapy Business (2015-2020))
13.1.5 Bluebird Bio Recent Development
13.2 Sangamo
13.2.1 Sangamo Company Details
13.2.2 Sangamo Business Overview and Its Total Revenue
13.2.3 Sangamo Gene Therapy Introduction
13.2.4 Sangamo Revenue in Gene Therapy Business (2015-2020)
13.2.5 Sangamo Recent Development
13.3 Spark Therapeutics
13.3.1 Spark Therapeutics Company Details
13.3.2 Spark Therapeutics Business Overview and Its Total Revenue
13.3.3 Spark Therapeutics Gene Therapy Introduction
13.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2015-2020)
13.3.5 Spark Therapeutics Recent Development
13.4 Dimension Therapeutics
13.4.1 Dimension Therapeutics Company Details
13.4.2 Dimension Therapeutics Business Overview and Its Total Revenue
13.4.3 Dimension Therapeutics Gene Therapy Introduction
13.4.4 Dimension Therapeutics Revenue in Gene Therapy Business (2015-2020)
13.4.5 Dimension Therapeutics Recent Development
13.5 Avalanche Bio
13.5.1 Avalanche Bio Company Details
13.5.2 Avalanche Bio Business Overview and Its Total Revenue
13.5.3 Avalanche Bio Gene Therapy Introduction
13.5.4 Avalanche Bio Revenue in Gene Therapy Business (2015-2020)
13.5.5 Avalanche Bio Recent Development
13.6 Celladon
13.6.1 Celladon Company Details
13.6.2 Celladon Business Overview and Its Total Revenue
13.6.3 Celladon Gene Therapy Introduction
13.6.4 Celladon Revenue in Gene Therapy Business (2015-2020)
13.6.5 Celladon Recent Development
13.7 Vical Inc.
13.7.1 Vical Inc. Company Details
13.7.2 Vical Inc. Business Overview and Its Total Revenue
13.7.3 Vical Inc. Gene Therapy Introduction
13.7.4 Vical Inc. Revenue in Gene Therapy Business (2015-2020)
13.7.5 Vical Inc. Recent Development
13.8 Advantagene
13.8.1 Advantagene Company Details
13.8.2 Advantagene Business Overview and Its Total Revenue
13.8.3 Advantagene Gene Therapy Introduction
13.8.4 Advantagene Revenue in Gene Therapy Business (2015-2020)
13.8.5 Advantagene Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Monogenic
1.5.4 Infectious disease
1.5.5 Cardiovascular disease
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapy Industry
1.6.1.1 Gene Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Gene Therapy Market Perspective (2015-2026)
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapy Players by Market Size
3.1.1 Global Top Gene Therapy Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy Market Concentration Ratio
3.2.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2019
3.3 Gene Therapy Key Players Head office and Area Served
3.4 Key Players Gene Therapy Product Solution and Service
3.5 Date of Enter into Gene Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gene Therapy Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy Forecasted Market Size by Type (2021-2026)
5 GENE THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gene Therapy Market Size by Application (2015-2020)
5.2 Global Gene Therapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gene Therapy Market Size (2015-2020)
6.2 Gene Therapy Key Players in North America (2019-2020)
6.3 North America Gene Therapy Market Size by Type (2015-2020)
6.4 North America Gene Therapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Gene Therapy Market Size (2015-2020)
7.2 Gene Therapy Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy Market Size by Type (2015-2020)
7.4 Europe Gene Therapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Gene Therapy Market Size (2015-2020)
8.2 Gene Therapy Key Players in China (2019-2020)
8.3 China Gene Therapy Market Size by Type (2015-2020)
8.4 China Gene Therapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Gene Therapy Market Size (2015-2020)
9.2 Gene Therapy Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy Market Size by Type (2015-2020)
9.4 Japan Gene Therapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Gene Therapy Market Size (2015-2020)
10.2 Gene Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy Market Size by Application (2015-2020)
11 INDIA
11.1 India Gene Therapy Market Size (2015-2020)
11.2 Gene Therapy Key Players in India (2019-2020)
11.3 India Gene Therapy Market Size by Type (2015-2020)
11.4 India Gene Therapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Gene Therapy Market Size (2015-2020)
12.2 Gene Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Bluebird Bio
13.1.1 Bluebird Bio Company Details
13.1.2 Bluebird Bio Business Overview and Its Total Revenue
13.1.3 Bluebird Bio Gene Therapy Introduction
13.1.4 Bluebird Bio Revenue in Gene Therapy Business (2015-2020))
13.1.5 Bluebird Bio Recent Development
13.2 Sangamo
13.2.1 Sangamo Company Details
13.2.2 Sangamo Business Overview and Its Total Revenue
13.2.3 Sangamo Gene Therapy Introduction
13.2.4 Sangamo Revenue in Gene Therapy Business (2015-2020)
13.2.5 Sangamo Recent Development
13.3 Spark Therapeutics
13.3.1 Spark Therapeutics Company Details
13.3.2 Spark Therapeutics Business Overview and Its Total Revenue
13.3.3 Spark Therapeutics Gene Therapy Introduction
13.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2015-2020)
13.3.5 Spark Therapeutics Recent Development
13.4 Dimension Therapeutics
13.4.1 Dimension Therapeutics Company Details
13.4.2 Dimension Therapeutics Business Overview and Its Total Revenue
13.4.3 Dimension Therapeutics Gene Therapy Introduction
13.4.4 Dimension Therapeutics Revenue in Gene Therapy Business (2015-2020)
13.4.5 Dimension Therapeutics Recent Development
13.5 Avalanche Bio
13.5.1 Avalanche Bio Company Details
13.5.2 Avalanche Bio Business Overview and Its Total Revenue
13.5.3 Avalanche Bio Gene Therapy Introduction
13.5.4 Avalanche Bio Revenue in Gene Therapy Business (2015-2020)
13.5.5 Avalanche Bio Recent Development
13.6 Celladon
13.6.1 Celladon Company Details
13.6.2 Celladon Business Overview and Its Total Revenue
13.6.3 Celladon Gene Therapy Introduction
13.6.4 Celladon Revenue in Gene Therapy Business (2015-2020)
13.6.5 Celladon Recent Development
13.7 Vical Inc.
13.7.1 Vical Inc. Company Details
13.7.2 Vical Inc. Business Overview and Its Total Revenue
13.7.3 Vical Inc. Gene Therapy Introduction
13.7.4 Vical Inc. Revenue in Gene Therapy Business (2015-2020)
13.7.5 Vical Inc. Recent Development
13.8 Advantagene
13.8.1 Advantagene Company Details
13.8.2 Advantagene Business Overview and Its Total Revenue
13.8.3 Advantagene Gene Therapy Introduction
13.8.4 Advantagene Revenue in Gene Therapy Business (2015-2020)
13.8.5 Advantagene Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Gene Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Therapy Revenue
Table 3. Ranking of Global Top Gene Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ex vivo
Table 6. Key Players of In Vivo
Table 7. COVID-19 Impact Global Market: (Four Gene Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gene Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gene Therapy Players to Combat Covid-19 Impact
Table 12. Global Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gene Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gene Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gene Therapy Market Share by Regions (2015-2020)
Table 16. Global Gene Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gene Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gene Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Gene Therapy Players
Table 23. Global Gene Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gene Therapy Market Share by Players (2015-2020)
Table 25. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2019)
Table 26. Global Gene Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gene Therapy Product Solution and Service
Table 29. Date of Enter into Gene Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gene Therapy Market Size Share by Type (2015-2020)
Table 33. Global Gene Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Gene Therapy Market Size Share by Application (2015-2020)
Table 35. Global Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gene Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gene Therapy Market Share (2019-2020)
Table 39. North America Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gene Therapy Market Share by Type (2015-2020)
Table 41. North America Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gene Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gene Therapy Market Share (2019-2020)
Table 45. Europe Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gene Therapy Market Share by Type (2015-2020)
Table 47. Europe Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gene Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gene Therapy Market Share (2019-2020)
Table 51. China Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Gene Therapy Market Share by Type (2015-2020)
Table 53. China Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Gene Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gene Therapy Market Share (2019-2020)
Table 57. Japan Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gene Therapy Market Share by Type (2015-2020)
Table 59. Japan Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gene Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gene Therapy Market Share (2019-2020)
Table 63. Southeast Asia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gene Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gene Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gene Therapy Market Share (2019-2020)
Table 69. India Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Gene Therapy Market Share by Type (2015-2020)
Table 71. India Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Gene Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gene Therapy Market Share (2019-2020)
Table 75. Central & South America Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gene Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gene Therapy Market Share by Application (2015-2020)
Table 79. Bluebird Bio Company Details
Table 80. Bluebird Bio Business Overview
Table 81. Bluebird Bio Product
Table 82. Bluebird Bio Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 83. Bluebird Bio Recent Development
Table 84. Sangamo Company Details
Table 85. Sangamo Business Overview
Table 86. Sangamo Product
Table 87. Sangamo Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 88. Sangamo Recent Development
Table 89. Spark Therapeutics Company Details
Table 90. Spark Therapeutics Business Overview
Table 91. Spark Therapeutics Product
Table 92. Spark Therapeutics Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 93. Spark Therapeutics Recent Development
Table 94. Dimension Therapeutics Company Details
Table 95. Dimension Therapeutics Business Overview
Table 96. Dimension Therapeutics Product
Table 97. Dimension Therapeutics Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 98. Dimension Therapeutics Recent Development
Table 99. Avalanche Bio Company Details
Table 100. Avalanche Bio Business Overview
Table 101. Avalanche Bio Product
Table 102. Avalanche Bio Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 103. Avalanche Bio Recent Development
Table 104. Celladon Company Details
Table 105. Celladon Business Overview
Table 106. Celladon Product
Table 107. Celladon Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 108. Celladon Recent Development
Table 109. Vical Inc. Company Details
Table 110. Vical Inc. Business Overview
Table 111. Vical Inc. Product
Table 112. Vical Inc. Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 113. Vical Inc. Recent Development
Table 114. Advantagene Business Overview
Table 115. Advantagene Product
Table 116. Advantagene Company Details
Table 117. Advantagene Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 118. Advantagene Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 1. Gene Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Therapy Revenue
Table 3. Ranking of Global Top Gene Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ex vivo
Table 6. Key Players of In Vivo
Table 7. COVID-19 Impact Global Market: (Four Gene Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gene Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gene Therapy Players to Combat Covid-19 Impact
Table 12. Global Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gene Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gene Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gene Therapy Market Share by Regions (2015-2020)
Table 16. Global Gene Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gene Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gene Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Gene Therapy Players
Table 23. Global Gene Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gene Therapy Market Share by Players (2015-2020)
Table 25. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2019)
Table 26. Global Gene Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gene Therapy Product Solution and Service
Table 29. Date of Enter into Gene Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gene Therapy Market Size Share by Type (2015-2020)
Table 33. Global Gene Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Gene Therapy Market Size Share by Application (2015-2020)
Table 35. Global Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gene Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gene Therapy Market Share (2019-2020)
Table 39. North America Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gene Therapy Market Share by Type (2015-2020)
Table 41. North America Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gene Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gene Therapy Market Share (2019-2020)
Table 45. Europe Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gene Therapy Market Share by Type (2015-2020)
Table 47. Europe Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gene Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gene Therapy Market Share (2019-2020)
Table 51. China Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Gene Therapy Market Share by Type (2015-2020)
Table 53. China Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Gene Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gene Therapy Market Share (2019-2020)
Table 57. Japan Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gene Therapy Market Share by Type (2015-2020)
Table 59. Japan Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gene Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gene Therapy Market Share (2019-2020)
Table 63. Southeast Asia Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gene Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gene Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gene Therapy Market Share (2019-2020)
Table 69. India Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Gene Therapy Market Share by Type (2015-2020)
Table 71. India Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Gene Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gene Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gene Therapy Market Share (2019-2020)
Table 75. Central & South America Gene Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gene Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Gene Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gene Therapy Market Share by Application (2015-2020)
Table 79. Bluebird Bio Company Details
Table 80. Bluebird Bio Business Overview
Table 81. Bluebird Bio Product
Table 82. Bluebird Bio Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 83. Bluebird Bio Recent Development
Table 84. Sangamo Company Details
Table 85. Sangamo Business Overview
Table 86. Sangamo Product
Table 87. Sangamo Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 88. Sangamo Recent Development
Table 89. Spark Therapeutics Company Details
Table 90. Spark Therapeutics Business Overview
Table 91. Spark Therapeutics Product
Table 92. Spark Therapeutics Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 93. Spark Therapeutics Recent Development
Table 94. Dimension Therapeutics Company Details
Table 95. Dimension Therapeutics Business Overview
Table 96. Dimension Therapeutics Product
Table 97. Dimension Therapeutics Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 98. Dimension Therapeutics Recent Development
Table 99. Avalanche Bio Company Details
Table 100. Avalanche Bio Business Overview
Table 101. Avalanche Bio Product
Table 102. Avalanche Bio Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 103. Avalanche Bio Recent Development
Table 104. Celladon Company Details
Table 105. Celladon Business Overview
Table 106. Celladon Product
Table 107. Celladon Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 108. Celladon Recent Development
Table 109. Vical Inc. Company Details
Table 110. Vical Inc. Business Overview
Table 111. Vical Inc. Product
Table 112. Vical Inc. Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 113. Vical Inc. Recent Development
Table 114. Advantagene Business Overview
Table 115. Advantagene Product
Table 116. Advantagene Company Details
Table 117. Advantagene Revenue in Gene Therapy Business (2015-2020) (Million US$)
Table 118. Advantagene Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Gene Therapy Market Share by Type: 2020 VS 2026
Figure 2. Ex vivo Features
Figure 3. In Vivo Features
Figure 4. Global Gene Therapy Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Monogenic Case Studies
Figure 7. Infectious disease Case Studies
Figure 8. Cardiovascular disease Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy Report Years Considered
Figure 11. Global Gene Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Gene Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Gene Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Gene Therapy Market Share by Players in 2019
Figure 16. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2019
Figure 18. North America Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bluebird Bio Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 27. Sangamo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sangamo Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 29. Spark Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 31. Dimension Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 33. Avalanche Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Avalanche Bio Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 35. Celladon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Celladon Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 37. Vical Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Vical Inc. Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 39. Advantagene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Advantagene Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Figure 1. Global Gene Therapy Market Share by Type: 2020 VS 2026
Figure 2. Ex vivo Features
Figure 3. In Vivo Features
Figure 4. Global Gene Therapy Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Monogenic Case Studies
Figure 7. Infectious disease Case Studies
Figure 8. Cardiovascular disease Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy Report Years Considered
Figure 11. Global Gene Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Gene Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Gene Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Gene Therapy Market Share by Players in 2019
Figure 16. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2019
Figure 18. North America Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Gene Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bluebird Bio Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 27. Sangamo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sangamo Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 29. Spark Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 31. Dimension Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 33. Avalanche Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Avalanche Bio Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 35. Celladon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Celladon Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 37. Vical Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Vical Inc. Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 39. Advantagene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Advantagene Revenue Growth Rate in Gene Therapy Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
